Contract 75F40123C00199
Mckesson Specialty Health Pharmaceutical & Biotech Solutions Llc · Department Of Health And Human Services · September 20, 2023
Mckesson Specialty Health Pharmaceutical & Biotech Solutions Llc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 20, 2023 for $2.95 million of work in research and development in the social sciences and humanities. Performance is in Irving, TX. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 23, 2025.
Contract details
- PIID
- 75F40123C00199
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541720 · Research And Development In The Social Sciences And Humanities
- Product / service
- Special Studies/Analysis- Scientific Data
- Place of performance
- Irving, TX
- First action
- September 20, 2023
- Latest action
- September 23, 2025
Description
P00002 - REVISING DELIVERABLES WITHIN THE SOW ----LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL C
Modification timeline
-
September 23, 2025Mod P00002P00002 - REVISING DELIVERABLES WITHIN THE SOW ----LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNIT$0
-
March 25, 2024Mod P00001LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL CONTEXT TO$0
-
September 20, 2023Base awardLEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL CONTEXT TO$2.95M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Advanced Regenerative Manufacturing Institute Inc | Department Of Health And Human Services | April 1, 2026 | $2.24M |
| Research Support Services | Department Of Health And Human Services | March 31, 2026 | $367.0K |
| The Lewin Group, Inc. | Department Of Health And Human Services | March 31, 2026 | $7.62M |
| Acumen Llc | Department Of Health And Human Services | March 30, 2026 | $43.42M |
| National Opinion Research Center | Department Of Health And Human Services | March 27, 2026 | $6.91M |
| American Institutes For Research In The Behavioral Sciences | Department Of Health And Human Services | March 26, 2026 | $4.23M |
Top contractors in NAICS 541720
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $18.76B |
| 2 | Westat, Inc. | 148 | $2.30B |
| 3 | Lockheed Martin Corp | 75 | $2.13B |
| 4 | Research Triangle Institute | 286 | $1.38B |
| 5 | The Rand Corporation | 690 | $1.21B |
| 6 | Mathematica Inc. | 133 | $985.21M |
| 7 | American Institutes For Research In The Behavioral Sciences | 123 | $826.55M |
| 8 | National Opinion Research Center | 105 | $805.13M |
| 9 | Educational Testing Service | 17 | $680.43M |
| 10 | Mathematica Inc. | 42 | $675.34M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40123C00199?
Contract 75F40123C00199 is a federal contract awarded to Mckesson Specialty Health Pharmaceutical & Biotech Solutions Llc by Department Of Health And Human Services on September 20, 2023 for $2.95 million of work classified under RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES. It has been modified 2 times since the base award.
Who won contract 75F40123C00199?
Mckesson Specialty Health Pharmaceutical & Biotech Solutions Llc won contract 75F40123C00199 from Department Of Health And Human Services.
How much is contract 75F40123C00199 worth?
Contract 75F40123C00199 has obligated $2.95 million to date.